Insights into gene therapy for critical limb ischemia: The devil is in the details

Vascular Pharmacology

Volumn 57, Issue 1, 2012, Pages 10-14

  Madonna, Rosalinda ^a   Rokosh, Gregg ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b University of Louisville School of Medicine   (United States)

Author keywords

Basic fibroblast growth factor; Critical limb ischemia; Gene therapy; Hepatocyte growth factor; Vascular endothelial growth factor

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; AQUAPORIN 1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMID DNA; PLASMID VECTOR; PROTEIN KINASE C; RAF PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AMPUTATION; ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANKLE BRACHIAL INDEX; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CRITICAL LIMB ISCHEMIA; DRUG ACTIVITY; ENDOTHELIUM CELL; GENE VECTOR; HUMAN; INFLAMMATION; LIMB SALVAGE; NONVIRAL GENE DELIVERY SYSTEM; PAIN ASSESSMENT; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RECEPTOR BINDING; REVIEW; RNA SPLICING; SAFETY; SKIN DEFECT; TRANSCUTANEOUS OXYGEN MONITORING; ULCER; WOUND HEALING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CLINICAL TRIALS AS TOPIC; GENETIC THERAPY; HUMANS; ISCHEMIA; LOWER EXTREMITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84862540404     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.05.001     Document Type: Review

References (41)

1. Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetto C., Comoglio P.M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996, 15:6205-6212.
2. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., Isner J.M. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998, 97:1114-1123.
3. Baumgartner I., Rauh G., Pieczek A., Wuensch D., Magner M., Kearney M., Schainfeld R., Isner J.M. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann. Intern. Med. 2000, 132:880-884.
4. Belch J., Hiatt W.R., Baumgartner I., Driver I.V., Nikol S., Norgren L., Van Belle E. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377:1929-1937.
5. Carlsson M., Osman N.F., Ursell P.C., Martin A.J., Saeed M. Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H522-H532.
6. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
7. Comerota A.J., Throm R.C., Miller K.A., Henry T., Chronos N., Laird J., Sequeira R., Kent C.K., Bacchetta M., Goldman C., Salenius J.P., Schmieder F.A., Pilsudski R. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J. Vasc. Surg. 2002, 35:930-936.
8. Coutts J.C., Gallagher J.T. Receptors for fibroblast growth factors. Immunol. Cell Biol. 1995, 73:584-589.
9. Fan S., Ma Y.X., Wang J.A., Yuan R.Q., Meng Q., Cao Y., Laterra J.J., Goldberg I.D., Rosen E.M. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene 2000, 19:2212-2223.
10. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989, 161:851-858.
11. Flaquer M., Franquesa M., Vidal A., Bolanos N., Torras J., Lloberas N., Herrero-Fresneda I., Grinyo J.M., Cruzado J.M. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012, Mar 30 Epub ahead of print.
12. Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., Polverini P., Rosen E.M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1937-1941.
13. Gu Y., Zhang J., Guo L., Cui S., Li X., Ding D., Kim J.M., Ho S.H., Hahn W., Kim S. A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia. J. Gene Med. 2011, 13:602-610.
14. Hahn W., Pyun W.B., Kim D.S., Yoo W.S., Lee S.D., Won J.H., Shin G.J., Kim J.M., Kim S. Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model. J. Gene Med. 2011, 13:549-555.
15. Henry T.D., Hirsch A.T., Goldman J., Wang Y.L., Lips D.L., McMillan W.D., Duval S., Biggs T.A., Keo H.H. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study. Gene Ther. 2011, 18:788-794.
16. Ishikawa H., Jo J.I., Tabata Y. Liver anti-fibrosis therapy with mesenchymal stem cells secreting hepatocyte growth factor. J. Biomater. Sci. Polym. Ed 2011, Dec 14 Epub ahead of print.
17. Isner J.M., Baumgartner I., Rauh G., Schainfeld R., Blair R., Manor O., Razvi S., Symes J.F. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg. 1998, 28:964-973. (discussion 973-965).
18. Kaga T., Kawano H., Sakaguchi M., Nakazawa T., Taniyama Y., Morishita R. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul. Pharmacol 2012, Feb 14 Epub ahead of print.
19. Liu F., Schaphorst K.L., Verin A.D., Jacobs K., Birukova A., Day R.M., Bogatcheva N., Bottaro D.P., Garcia J.G. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J. 2002, 16:950-962.
20. Masaki I., Yonemitsu Y., Yamashita A., Sata S., Tanii M., Komori K., Nakagawa K., Hou X., Nagai Y., Hasegawa M., Sugimachi K., Sueishi K. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res. 2002, 90:966-973.
21. Meij J.T., Sheikh F., Jimenez S.K., Nickerson P.W., Kardami E., Cattini P.A. Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H547-H555.
22. Moscatelli D., Joseph-Silverstein J., Presta M., Rifkin D.B. Multiple forms of an angiogenesis factor: basic fibroblast growth factor. Biochimie 1988, 70:83-87.
23. Nikol S., Baumgartner I., Van Belle E., Diehm C., Visona A., Capogrossi M.C., Ferreira-Maldent N., Gallino A., Wyatt M.G., Wijesinghe L.D., Fusari M., Stephan D., Emmerich J., Pompilio G., Vermassen F., Pham E., Grek V., Coleman M., Meyer F. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 2008, 16:972-978.
24. Okayama K., Azuma J., Dosaka N., Iekushi K., Sanada F., Kusunoki H., Iwabayashi M., Rakugi H., Taniyama Y., Morishita R. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition. Hypertension 2012, 59:958-965.
25. Powell R.J., Simons M., Mendelsohn F.O., Daniel G., Henry T.D., Koga M., Morishita R., Annex B.H. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008, 118:58-65.
26. Pyun W.B., Hahn W., Kim D.S., Yoo W.S., Lee S.D., Won J.H., Rho B.S., Park Z.Y., Kim J.M., Kim S. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Ther. 2010, 17:1442-1452.
27. Saadoun S., Papadopoulos M.C., Hara-Chikuma M., Verkman A.S. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005, 434:786-792.
28. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., Shapiro R.L., Galloway A.C., Rifkin D.B., Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 1998, 141:1659-1673.
29. Seki T., Hagiya M., Shimonishi M., Nakamura T., Shimizu S. Organization of the human hepatocyte growth factor-encoding gene. Gene 1991, 102:213-219.
30. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
31. Shigematsu H., Yasuda K., Iwai T., Sasajima T., Ishimaru S., Ohashi Y., Yamaguchi T., Ogihara T., Morishita R. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010, 17:1152-1161.
32. Shyu K.G., Chang H., Isner J.M. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci. 2003, 73:563-579.
33. Taniyama Y., Morishita R., Aoki M., Hiraoka K., Yamasaki K., Hashiya N., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002, 40:47-53.
34. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
35. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
36. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., Isner J.M. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998, 97:381-390.
37. Wang F., Yamauchi M., Muramatsu M., Osawa T., Tsuchida R., Shibuya M. RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway. J. Biol. Chem. 2011, 286:9097-9106.
38. Xia P., Aiello L.P., Ishii H., Jiang Z.Y., Park D.J., Robinson G.S., Takagi H., Newsome W.P., Jirousek M.R., King G.L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 1996, 98:2018-2026.
39. Xin X., Yang S., Ingle G., Zlot C., Rangell L., Kowalski J., Schwall R., Ferrara N., Gerritsen M.E. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 2001, 158:1111-1120.
40. Yamashita A., Yonemitsu Y., Okano S., Nakagawa K., Nakashima Y., Irisa T., Iwamoto Y., Nagai Y., Hasegawa M., Sueishi K. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J. Immunol. 2002, 168:450-457.
41. Zittermann S.I., Issekutz A.C. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J. Leukoc. Biol. 2006, 80:247-257.